Increased interleukin 10 (IL10) and tumor necrosis factor-alpha (TNFA) gene expression levels in PBMC of CIDP patients compared to healthy controls. This evidence concerns the gene IL10 and chronic inflammatory demyelinating polyradiculoneuropathy.